Unknown

Dataset Information

Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial.


ABSTRACT:

Background

Vitamin C is an essential water-soluble nutrient that functions as a key antioxidant and has been proven to be effective for boosting immunity. In this study, we aimed to assess the efficacy of adding high-dose intravenous vitamin C (HDIVC) to the regimens for patients with severe COVID-19 disease.

Methods

An open-label, randomized, and controlled trial was conducted on patients with severe COVID-19 infection. The case and control treatment groups each consisted of 30 patients. The control group received lopinavir/ritonavir and hydroxychloroquine and the case group received HDIVC (6 g daily) added to the same regimen.

Results

There were no statistically significant differences between two groups with respect to age and gender, laboratory results, and underl

SUBMITTER: JamaliMoghadamSiahkali S 

PROVIDER: S-EPMC7877333 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature